News Focus
News Focus
Replies to #83661 on Biotech Values
icon url

genisi

09/19/09 4:57 AM

#83769 RE: DewDiligence #83661

Next on the list is FTY720, and there's Tasigna in front-line CML, which is important for NVS, who will face competition from Sprycel and wants to protect from Gleevec's patent expiration.